Han Dong, Zhang Jiafeng, Shah Aakash, Griffith Bartley P, Wu Zhongjun J
From the Department of Surgery, University of Maryland School of Medicine, Baltimore, Maryland.
Fischell Department of Bioengineering, A. James Clark School of Engineering, University of Maryland, College Park, Maryland.
ASAIO J. 2025 Sep 1;71(9):719-726. doi: 10.1097/MAT.0000000000002396. Epub 2025 Feb 19.
Although extracorporeal membrane oxygenation (ECMO) systems have been used to provide temporary support for patients with severe respiratory or cardiac failure, they are often bedridden, in part because of their bulky size which relies solely on an unlimited source of wall oxygen. However, there is an unmet clinical need for ambulatory ECMO which necessitates downsizing the ECMO system. We sought to develop a new oxygenator to reduce the dependence on the oxygen supply source. The proposed oxygenator features a dual-chamber gas exchangers, with one chamber primarily responsible for carbon dioxide removal using ambient air and a subsequent chamber primarily responsible for oxygen transfer using pure oxygen. Computational fluid dynamics was used to analyze the blood flow field to avoid adverse stagnation and optimize gas exchange performance. Bovine blood was used for in vitro gas transfer test. This new oxygenator demonstrated the capability to provide adequate respiratory support (both carbon dioxide removal and oxygen transfer) to adult patients at blood rate of 4-6 L/min with an oxygen supply of only 2 L/min. The reduced use of oxygen with this new oxygenator may pave the way for the development of potable ECMO systems.
尽管体外膜肺氧合(ECMO)系统已被用于为严重呼吸或心力衰竭患者提供临时支持,但患者往往需要卧床,部分原因是其体积庞大,且完全依赖无限的壁式氧气源。然而,对于可移动的ECMO存在未满足的临床需求,这就需要缩小ECMO系统的尺寸。我们试图开发一种新的氧合器,以减少对氧气供应源的依赖。所提出的氧合器具有双腔气体交换器,其中一个腔室主要负责利用环境空气去除二氧化碳,随后的腔室主要负责利用纯氧进行氧气传输。采用计算流体动力学分析血流场,以避免不利的停滞现象并优化气体交换性能。使用牛血进行体外气体传输测试。这种新型氧合器证明,在仅2升/分钟的氧气供应下,以4-6升/分钟的血流速率可为成年患者提供足够的呼吸支持(包括二氧化碳去除和氧气传输)。这种新型氧合器减少氧气使用量,可能为便携式ECMO系统的开发铺平道路。